Bastide Le Confort Médical S.A.
BLC.PA · PAR
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.78 | 1.48 | -1.46 | 11.57 |
| FCF Yield | 17.86% | 7.45% | 16.14% | -2.51% |
| EV / EBITDA | 6.07 | 4.92 | 6.29 | 7.31 |
| Quality | ||||
| ROIC | 3.07% | 4.50% | 5.16% | 4.55% |
| Gross Margin | 67.80% | 66.91% | 65.69% | 65.51% |
| Cash Conversion Ratio | 65.27 | 8.95 | 5.62 | 3.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.12% | 4.20% | 4.59% | 6.96% |
| Free Cash Flow Growth | 292.22% | -70.96% | 662.66% | -133.20% |
| Safety | ||||
| Net Debt / EBITDA | 3.78 | 3.59 | 3.98 | 4.42 |
| Interest Coverage | 1.27 | 1.42 | 2.21 | 2.55 |
| Efficiency | ||||
| Inventory Turnover | 3.96 | 2.97 | 2.89 | 2.63 |
| Cash Conversion Cycle | -5.64 | 36.50 | 42.51 | 69.51 |